Survival of guselkumab therapy in moderate to severe plaque psoriasis at 52 weeks in a real-world clinical setting: observational, retrospective, multi-centre study by the Spanish Psoriasis Group

JOURNAL OF DERMATOLOGICAL TREATMENT(2022)

引用 4|浏览5
暂无评分
关键词
clinical practice,guselkumab,psoriasis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要